Related Experiment Video
Updated: Nov 8, 2025
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Multi-scale modeling for systematically understanding the key roles of microglia in AD development
Zhiwei Ji1, Changan Liu2, Weiling Zhao2
1College of Artificial Intelligence, Nanjing Agricultural University, No.1 Weigang Road, Nanjing, Jiangsu, 210095, China; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, 7000 Fannin Street, Houston, TX, 77030, USA.
Abstract:
Alzheimer's disease (AD) is the leading cause of age-related dementia, affecting over 5 million people in the United States. Unfortunately, current therapies are largely palliative and several potential drug candidates have failed in late-stage clinical trials. Studies suggest that microglia-mediated neuroinflammation might be responsible for the failures of various therapies. Microglia contribute to Aβ clearance in the early stage of neurodegeneration and may contribute to AD development at the late stage by releasing pro-inflammatory cytokines. However, the activation profile and phenotypic changes of microglia during the development of AD are poorly understood. To systematically understand the key role of microglia in AD progression and predict the optimal therapeutic strategy in silico, we developed a 3D multi-scale model of AD (MSMAD) by integrating multi-level experimental data, to manipulate the neurodegeneration in a simulated system. Based on our analysis, we revealed that how TREM2-related signal transduction leads to an imbalance in the activation of different microglia phenotypes, thereby promoting AD development. Our MSMAD model also provides an optimal therapeutic strategy for improving the outcome of AD treatment.
Insights
Researchers developed a 3D model to understand Alzheimer's disease (AD) progression. The study reveals how TREM2 signaling impacts microglia, offering insights for better AD therapies.
Area of Science:
- Neuroscience
- Computational Biology
- Immunology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, with limited effective treatments.
- Microglia-mediated neuroinflammation is implicated in AD pathogenesis and therapy failure.
- The precise role and activation states of microglia in AD progression remain unclear.
Purpose of the Study:
- To systematically investigate the role of microglia in Alzheimer's disease (AD) progression.
- To predict optimal therapeutic strategies for AD using computational modeling.
- To elucidate the mechanisms underlying microglia-mediated neuroinflammation in AD.
Main Methods:
- Development of a 3D multi-scale model of Alzheimer's disease (MSMAD) integrating multi-level experimental data.
- In silico simulation of neurodegeneration to analyze AD progression.
- Analysis of TREM2-related signal transduction pathways and microglia phenotype activation.
Main Results:
- The MSMAD model revealed how TREM2 signaling disrupts microglia phenotype balance, exacerbating AD development.
- Identified specific microglia activation profiles and phenotypic changes during AD progression.
- The model predicted an optimal therapeutic strategy to improve AD treatment outcomes.
Conclusions:
- Microglia play a critical, complex role in Alzheimer's disease progression, influenced by TREM2 signaling.
- The developed MSMAD model serves as a valuable tool for understanding AD pathogenesis.
- Computational modeling can guide the development of more effective therapeutic interventions for Alzheimer's disease.
